国产a级特黄的片子,精品香蕉一区二区三区,亚洲精品99久久久久中文字幕,无码精品A∨在线观看无广告

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

日韩精品一区| 人乱AN乱ALV老人乱| 国产麻豆VIDEOXXXX实拍| 亚洲AV色欲色欲WWW| 国产线路3国产线路2| 先の欲求不満な人妻在线| 国产亚洲精品久久久久久小舞| 国产av一区二区三区| 欧美在线人一区二区三区| 欧亚乱熟女一区二区在线| 国产尤物AV尤物在线观看| 亚洲av无码电影在线播放| 无码中文字幕色专区| 国精品无码一区二区三区在线蜜臀| 少妇性l交大片| 波多野结av衣东京热无码专区| 51久久成人国产精品麻豆| 国产午夜福利久久精品| 国产精品无码无片在线观看3d| 狠狠色噜噜狠狠狠狠色综合久 | 国产95在线 | 欧美| 国产人与zoxxxx另类| 日韩国产精品亚洲а∨天堂免 | www.五月天| 色欲精品国产一区二区三区| 国产人妻人伦精品| 国产精品久久久久久亚洲毛片 | 最新精品国偷自产在线69| 麻豆妓女爽爽一区二区三| 五月丁香综合激情六月久久| 97性无码区免费| 一区二区三区在线 | 网站| 久久久久久久99精品国产片| 阳茎伸入女人阳道视频免费| 99国产精品久久久久久久日本竹| 肥臀熟女一区二区三区| 少妇人妻av毛片在线看 | 久久久精品人妻一区亚美研究所| 无码人妻精品一区二区蜜桃网站| 人人妻人人爽人人澡欧美一区 | 99re6热在线精品视频播放|